Medical Condition

hypogonadotropic hypogonadism

Total Trials

3

Recruiting Now

3

Trial Phases

Phase 2

ClinicalMetric tracks all active clinical trials for hypogonadotropic hypogonadism sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Trial Phases

Phase 2

Top Sponsors

Centre Hospitalier Universitaire Vaudois 1 trial

University of Colorado, Denver 1 trial

Stephanie B. Seminara, MD 1 trial

Recruiting Clinical Trials

NCT01601171

Recruiting

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Centre Hospitalier Universitai...

View Trial →

NCT06357442

Recruiting

Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.

University of Colorado, Denver

View Trial →

NCT05896293 Phase 2

Recruiting

Kisspeptin Administration Subcutaneously to Patients With IHH

Stephanie B. Seminara, MD

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology